Neuronetics STIM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$37.23M+23.3% | -$39.14M+10.5% | -$44.61M-22.5% | -$48.55M-49.5% | -$48.54M-76.3% | ||
| $3.3M+36.1% | $3.47M+67.1% | $3.14M+47.6% | $2.77M+30.8% | $2.42M+18.2% | ||
| $7.08M+24.1% | $6.85M+22.2% | $5.95M+0.1% | $5.96M-6.6% | $5.71M-16.7% | ||
| $891K+11.5% | $824K+6.9% | $791K+4.9% | $685K-12.8% | $799K+31.6% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$7.18M-289% | -$3.54M-192% | -$1.38M-129% | $3.11M-52.7% | $3.79M-58.6% | ||
| —— | —— | —— | -$515K— | -$2M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $620K+356% | $257K+489% | -$239.5K— | -$353K— | -$242.5K— | ||
| —— | —— | —— | —— | -$939K-3.8% | ||
| -$13.71M+61.9% | -$21.28M+31.3% | -$29.88M-33.4% | -$34.51M-27.3% | -$35.98M-16.1% | ||
| $779K-40.5% | $801K-45.4% | $674K-70.1% | $946K-60.9% | $1.31M-47.8% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$754K+72.2% | -$801K+67.0% | -$2.96M-382% | -$2.85M-364% | -$2.71M-139% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $20.7M+2,069,975% | ||
| $147.5K— | $94K— | —— | —— | —— | ||
| $625K— | $500K— | —— | —— | —— | ||
| $12.33M-11.1% | $36.88M+642% | $35.18M+105% | $15.57M— | $13.87M— | ||
| -$1.92M+92.7% | $15.01M+137% | $13.6M— | -$25.17M— | -$26.51M— | ||
| $7.88M+19.8% | $7.59M+16.6% | $7.04M+6.4% | $6.67M+10.4% | $6.57M+21.9% | ||
| $891K+11.5% | $824K+6.9% | $791K+4.9% | $685K-12.8% | $799K+31.6% | ||
| —— | —— | —— | —— | —— | ||
| $88K+111% | $31K+103% | -$165K+82.7% | -$395K+59.7% | -$777K+12.9% | ||
| -$1.22M-325% | -$958K-187% | -$514K-140% | $1K-99.9% | $541K-58.3% | ||
| -$1.77M-244% | -$4.67M-505% | -$3.03M— | -$1.52M— | -$514K— | ||
| $353K-37.0% | $388K-38.0% | $547K— | $709K— | $560K— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $147.5K— | $94K— | —— | —— | —— | ||
| —— | $211K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$939K-3.8% | ||
| $625K— | $500K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$14.27M+61.7% | -$21.87M+32.6% | -$30.55M-28.5% | -$35.46M-23.8% | -$37.29M-14.4% | ||
| -$14.27M+61.7% | -$21.87M+32.6% | -$30.55M-28.5% | -$35.46M-23.8% | -$37.29M-14.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Neuronetics generate?
- Neuronetics (STIM) generated -$13.7M in operating cash flow over the trailing twelve months.
- What is Neuronetics's free cash flow?
- After $779.0K of capital expenditures, Neuronetics's free cash flow was -$14.3M over the trailing twelve months, up 61.7% year over year.
- Where does Neuronetics's cash flow data come from?
- Every line is extracted from Neuronetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
